An aggressive lactotroph pituitary tumor in a young male: A pituitary carcinoma without metastasis.

IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY
Friederike E Roelandt-Schumann, R. Vergeer, A. G. Korsten-Meijer, M. Kramer, H. Westerlaan, J. Pott, J. Nuver, G. van den Berg, W. D. Den Dunnen
{"title":"An aggressive lactotroph pituitary tumor in a young male: A pituitary carcinoma without metastasis.","authors":"Friederike E Roelandt-Schumann, R. Vergeer, A. G. Korsten-Meijer, M. Kramer, H. Westerlaan, J. Pott, J. Nuver, G. van den Berg, W. D. Den Dunnen","doi":"10.5414/NP301458","DOIUrl":null,"url":null,"abstract":"This case report concerns a 31-year-old male with an aggressive pituitary tumor who presented initially with bitemporal hemianopsia and slightly elevated prolactin. On magnetic resonance imaging of the brain, there was a sellar mass with parasellar invasion to the lateral aspects of the internal carotid arteries, compressing the optic chiasm. On histopathological analysis, the diagnosis was made of a densely granulated lactotroph pituitary tumor with a Ki67 proliferation rate of 15%, a mitotic count of 6/10 high-power fields, and p53 positivity. Based on these features, the tumor was classified as a grade 2b tumor according to the Trouillas classification, and a more aggressive behavior of the tumor could be expected. In order to anticipate a future need for alternative drug treatments, the following analyses were undertaken: MGMT methylation (present) as well as the expression of estrogen receptor (negative), programmed-death ligand 1 (60 - 70% positive tumor cells), vascular endothelial growth factor-A and somatostatin receptor 2 (both positive). There was regrowth of residual tumor tissue, and the treatment consisted thus far of repeat surgery, cabergoline, pasireotide, and radiotherapy. Chemotherapy with temozolomide could not yet be initiated due to a concurrent infertility treatment. This case is unique because the tumor displays atypical characteristics, both in terms of morphology and behavior. It also illustrates how pathologists can play an important role in determining the diagnosis, prognosis, and possibilities for targeted therapy.","PeriodicalId":55251,"journal":{"name":"Clinical Neuropathology","volume":"1 1","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2022-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neuropathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5414/NP301458","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

This case report concerns a 31-year-old male with an aggressive pituitary tumor who presented initially with bitemporal hemianopsia and slightly elevated prolactin. On magnetic resonance imaging of the brain, there was a sellar mass with parasellar invasion to the lateral aspects of the internal carotid arteries, compressing the optic chiasm. On histopathological analysis, the diagnosis was made of a densely granulated lactotroph pituitary tumor with a Ki67 proliferation rate of 15%, a mitotic count of 6/10 high-power fields, and p53 positivity. Based on these features, the tumor was classified as a grade 2b tumor according to the Trouillas classification, and a more aggressive behavior of the tumor could be expected. In order to anticipate a future need for alternative drug treatments, the following analyses were undertaken: MGMT methylation (present) as well as the expression of estrogen receptor (negative), programmed-death ligand 1 (60 - 70% positive tumor cells), vascular endothelial growth factor-A and somatostatin receptor 2 (both positive). There was regrowth of residual tumor tissue, and the treatment consisted thus far of repeat surgery, cabergoline, pasireotide, and radiotherapy. Chemotherapy with temozolomide could not yet be initiated due to a concurrent infertility treatment. This case is unique because the tumor displays atypical characteristics, both in terms of morphology and behavior. It also illustrates how pathologists can play an important role in determining the diagnosis, prognosis, and possibilities for targeted therapy.
一例年轻男性的侵袭性乳营养垂体瘤:一例无转移的垂体癌。
本病例报告涉及一名患有侵袭性垂体瘤的31岁男性,最初表现为双颞侧偏盲和泌乳素轻度升高。在大脑的磁共振成像中,有一个鞍区肿块,鞍旁侵犯颈内动脉的外侧,压迫视交叉。在组织病理学分析中,诊断为致密颗粒的乳营养垂体瘤,Ki67增殖率为15%,有丝分裂计数为6/10高倍视野,p53阳性。基于这些特征,根据Trouillas分类,该肿瘤被归类为2b级肿瘤,预计肿瘤会有更具侵袭性的行为。为了预测未来对替代药物治疗的需求,进行了以下分析:MGMT甲基化(存在)以及雌激素受体(阴性)、程序性死亡配体1(60-70%阳性肿瘤细胞)、血管内皮生长因子-a和生长抑素受体2(均为阳性)的表达。残余肿瘤组织再生,迄今为止的治疗包括重复手术、卡麦角林、帕西核苷酸和放射治疗。由于同时进行不孕不育治疗,替莫唑胺的化疗尚未开始。这种情况是独特的,因为肿瘤在形态和行为方面都表现出非典型特征。它还说明了病理学家如何在确定诊断、预后和靶向治疗的可能性方面发挥重要作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Neuropathology
Clinical Neuropathology 医学-病理学
CiteScore
1.60
自引率
0.00%
发文量
70
审稿时长
>12 weeks
期刊介绍: Clinical Neuropathology appears bi-monthly and publishes reviews and editorials, original papers, short communications and reports on recent advances in the entire field of clinical neuropathology. Papers on experimental neuropathologic subjects are accepted if they bear a close relationship to human diseases. Correspondence (letters to the editors) and current information including book announcements will also be published.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信